The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.

How likely is it for President Trump's new drug-pricing plan to be implemented? And will we see a return of Elizabeth Holmes' blood-testing ambitions? All that and more on "The Readout LOUD" podcast.

The UNC technology, developed by Pediatrics Professor Chengwen Li, M.D., Ph.D., uses adeno-associated viruses (AAVs) to ferry ...

Biotech firm NTxBio is establishing a facility in Plano, promising over 170 new jobs and a $31 million investment.

BNT324, a bispecific antibody candidate under development by BioNTech (NASDAQ:BNTX) that is seen as critical to the biotech's ...

Find out the best way to find the right CDMO for your biotech. Experts shared some advice to help companies through the ...

Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...

Biotech investors are preparing for what may be the most important clinical trial readout for them this summer.

GEN talked with several contract development and manufacturing organizations (CDMOs) and/or contract research organizations (CROs) about new ways they are addressing AAV manufacturing challenges.

Shares of Septerna Inc. were soaring in Wednesday trading after the biotech clinched a partnership with Wegovy and Ozempic parent Novo Nordisk to collaborate on oral obesity and Type 2 diabetes ...

Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last ...